Policy Sections
Mini Sections
Advertising rules for prescription medicines, which is currently banned in Europe, could be relaxed in one of the most controversial initiatives expected in the Commission’s upcoming pharmaceuticals package, due in October.
While the European Food Safety Authority (EFSA) has found no clear safety concerns related to food products from clones of cattle, pigs or their offspring, it strongly underlines that no way near enough scientific data on the subject exists as yet and that the practice has major repercussions on animal health and welfare.
Increased cross-border patient mobility has public finance implications but better co-ordination of national health policies and more co-operation at European level is expected to bring benefits both to patients and health systems. (read more)
Patients' health records saved in databases could boost the efficiency of health markets in the EU but pose major challenges regarding interoperability and safeguarding patient privacy. (read more)
eHealth, one of the priorities of the EU's i2010 programme to boost innovation and jobs, aims to provide user-friendly and interoperable information systems for patients and health professionals across Europe. (read more)